I applaud the company for Learning from their mistakes.

$AVXL What a pro active company Biovie. .incredible.

But this company has something great!

But this company has something great

But the company actually has never seen before wonderful results.

$AVXL this is by far one of the most promising companies that I’ve followed.

$AVXL Anavex is ahead of all the other biotechnology companies now. .

Good luck to all the long holders of both of these outstanding companies!!!!

It’s literally twice as good as the “other company”, without the Brain bleeds.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

$TGTX MOST CONVENIENT- 50% faster infusion SAFEST - Zero Breast Cancer Risk MOST AFFORDABLE - By far If TGTX was a Big Pharma Company, the medical press would be blowing it up with praise.

Everyone knows that the value of this company is very high.

Getting the current best treatment at the most respectable affordable price is the sweetest deal and gesture that a company can offer.

$TGTX is definitely a good company, and worth double what it is right now!

Not only do they have the best-in-class treatment, they also have the best-in-class team hired from premier MS companies such as Biogen, Bristol Myers Squibb, Celgene, Genentech, Novartis, and Roche.

I am long believe in company

$IMMX This is the "Nothing But Good News Company".

Stock could easily go to $4.50 in next 60 days and if they get 80% ORR in solid tumors this will be a multi-billion dollar company.

$TCBP has a float of about 800k shares that's considerd to be a real micro float company, so I think that we could see some big moves to the upside in the next couple of days.

Kala Pharmaceuticals (NASDSAQ: KALA): The company tops the leaderboard moving up 15 places from the prior week.

$KALA hold you stock..this is a successful company and definitely bouncing up higher than the 50$

$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.

$KALA Real company with a desirable product.